Vinati Organics Q3 Review - Re-Fuelling For Growth, Valuations Factor Almost Everything: Dolat Capital

BQ Blue's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer BloombergQuint's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Dolat Capital Report

Vinati Organics Ltd. reported a good sales performance registering 65.1% YoY growth to Rs 3.69 billion (our estimate: Rs 3.85 billion). Margin woes have been persistent as gross margins decline by 601 basis points YoY to 48.9%.

• 
  Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon
• 
  NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term
• 
  Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani
• 
  'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps
• 
  India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers
• 
  'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax
• 
  Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite
• 
  Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness
• 
  CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE
• 
  Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI

Ebitda growth was at 28.7% YoY to Rs 928 million. Ebitda margins stood at 25.1%, down 710 bps YoY due to higher opex at Rs 663 million, up 105.7% YoY.

Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay

Vinati Organics' profit after tax grew higher at 29.8% YoY to Rs 833 million owing to a tax reversal impending from last year, which effectively brought the tax rate down to 13%.

Acrylamide tertiary-butyl sulfonic acid sales were at ~Rs 1.84 billion (50% of sales), butyl phenols were at ~Rs 443 million (12% of sales), isobutyl benzene sales were at Rs 295 million (~8% of sales) while other products took the rest of 30% of sales.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.